A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions.
about
Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives.Making genomic medicine evidence-based and patient-centered: a structured review and landscape analysis of comparative effectiveness researchAdvances and challenges in hereditary cancer pharmacogenetics.The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.Economic Evaluations of Thrombophilia Screening Prior to Prescribing Combined Oral Contraceptives: A Systematic and Critical Review.Is Universal HLA-B*15:02 Screening a Cost-Effective Option in an Ethnically-Diverse Population? A Case Study of Malaysia.Distribution of CYP2C19 polymorphisms in Mongolian and Han nationals and the choice of specific antiplatelet drugs.The influence of big (clinical) data and genomics on precision medicine and drug development.An assessment of the impact of pharmacogenomics on health disparities: a systematic literature review.Cost-effectiveness of HLA-B*15:02 screening in Malaysia.Early health technology assessments in pharmacogenomics: a case example in cardiovascular drugs.HLA-associated drug hypersensitivity and the prediction of adverse drug reactions.The challenges of implementing pharmacogenomic testing in the clinic.Pharmacogenomic Advances in the Prediction and Prevention of Cutaneous Idiosyncratic Drug Reactions.Precision Medicine: From Science To Value.The economic case for precision medicine.
P2860
Q38643129-C3100881-CC62-468F-9701-809ED3A962ADQ38730837-DCB24052-8545-4923-9A33-BDD05F507970Q38948499-8672381E-1661-4B2A-A49D-E1895412D744Q39136036-EE5234DD-FC69-4E77-B949-D5165B9BCB95Q39177130-EFB1302B-846E-4BBE-84E9-A87F692C54BAQ40271934-6F177F95-EF4B-46F1-BBEA-3E62B1AF0A73Q41223244-031D1FFE-1715-4249-A044-59D6BEC7FB10Q45943634-2C09EDA6-F79A-4592-9828-DE2F71EFAD87Q47622750-9A35BDEC-E7B3-4AD5-9763-FDBE75EDA245Q47624981-6A41A1FE-CA71-403D-BEBD-8E8B9091274DQ47821070-3C380FA9-0CEE-43D0-B597-6EC7515792BFQ47826173-1F3675DC-B049-4A4E-811F-0887FCF3A4EDQ47929031-28C645CB-5438-453C-9EC5-6C43155D6676Q52702236-A6CFBEEF-F30C-4727-AF3A-1FB960532CE6Q55072280-7B37C761-E5FA-4740-B29A-FF15C2A7A042Q55217201-2E9D1F6E-9464-4972-A145-DEE9243FC102
P2860
A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A Systematic Review of Economi ...... ion of Adverse Drug Reactions.
@en
type
label
A Systematic Review of Economi ...... ion of Adverse Drug Reactions.
@en
prefLabel
A Systematic Review of Economi ...... ion of Adverse Drug Reactions.
@en
P2860
P50
P1433
P1476
A Systematic Review of Economi ...... tion of Adverse Drug Reactions
@en
P2093
Daniel Roberts
P2860
P2888
P304
P356
10.1007/S40273-016-0397-9
P577
2016-08-01T00:00:00Z